Common reactions include nausea, diarrhea, or vomiting, which typically lessen with time
Yes, Tirzepatide outperforms Semaglutide for weight loss based on head-to-head clinical trial data
The full results will be shared at Alzheimers conferences in 2026, giving researchers a chance to dig into subgroups and additional findings that havent been released yet
Identity and Contact Information of the Data Controller This privacy policy applies to all personal data processed by Sensilab d.o.o., with its registered office at Verovkova 55a, 1000 Ljubljana, Slovenia, , company registration number 2113732000, and Vision Healthcare Group, with its registered office at Grote Markt 41, 8500 Kortrijk, Belgium, company registration number BE 0685.849.188, acting as joint controllers under the GDPR (hereafter called 'Data Controller')
Injection Site Reactions : Redness or irritation at the injection site is possible but usually fades quickly